Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes

Cancer Letters
Hengyi ChenYong He

Abstract

Acquired resistance has become the bottleneck affecting the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment. Studies have shown that the antidiabetic drug metformin could effectively increase the sensitivity of TKI-resistant lung cancer cells to EGFR-TKI. This study aimed to evaluate the effect of metformin in combination with EGFR-TKI on the prognosis of non-small cell lung cancer (NSCLC) patients with diabetes mellitus type 2 (DM2). Data of NSCLC patients with DM2 who received treatment in six hospitals in China between January 2006 and January 2014 were reviewed retrospectively. They were divided into two groups: Group A, where the patients (n = 44) received EGFR-TKI plus metformin; and Group B, where the patients (n = 46) received EGFR-TKI plus hypoglycemic agents other than metformin. Prognostic differences between the two groups were assessed. The median progression-free survival (PFS) and median overall survival (OS) in Group A were significantly longer than those in Group B (19.0 months vs. 8.0 months, P = .005; 32.0 months vs. 23.0 months, P = .002). The objective response rate (ORR) and disease control rate (DCR) in Group A were significantly higher than those in Group B (...Continue Reading

References

Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lecia V SequistThomas J Lynch
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Jan 21, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yelena Y JanjigianGregory J Riely
May 6, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guilherme Z RochaJosé B C Carvalheira
Nov 1, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Barbara SalaniDavide Maggi
Nov 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard J Appleman
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Aug 28, 2012·Diabetes Care·Brielan B SmiechowskiSamy Suissa
May 23, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Floriana MorgilloFortunato Ciardiello
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Mar 20, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Li LiYong He
Jun 7, 2014·Molecular and Cellular Endocrinology·Sun Wook ChoDo Joon Park
Jun 13, 2014·Expert Opinion on Investigational Drugs·Chieh-Chien LeeHsing-Pang Hsieh
Oct 1, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ming-Ju TsaiHerng-Chia Chiu
Dec 3, 2014·American Journal of Obstetrics and Gynecology·Ernst LengyelIris L Romero
Dec 19, 2014·American Journal of Respiratory and Critical Care Medicine·Jenny J LinJuan P Wisnivesky
Apr 30, 2015·The New England Journal of Medicine·Lecia V SequistD Ross Camidge
Aug 6, 2015·The New England Journal of Medicine·Lecia V SequistAndrew R Allen

❮ Previous
Next ❯

Citations

Apr 28, 2016·Cancer Chemotherapy and Pharmacology·Hui-Hui Zhang, Xiu-Li Guo
Dec 17, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R Shah
May 5, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shaohua Cui, Liyan Jiang
Dec 5, 2017·Indian Journal of Cancer·S ZhongJ Zhao
Mar 22, 2019·The Cancer Journal·Joseph C Murray, Benjamin Levy
Aug 15, 2019·Integrative Cancer Therapies·Ming-Szu HungYao-Hsu Yang
Sep 7, 2018·Frontiers in Endocrinology·Sylvia AndrzejewskiJulie St-Pierre
Sep 29, 2019·The Clinical Respiratory Journal·Hengyi ChenYong He
Mar 12, 2020·International Journal of Environmental Research and Public Health·Edvardas DanilaGiedrė Smailytė
Feb 12, 2020·Cell Death & Disease·Hengyi ChenYong He
Oct 31, 2020·Cellular Oncology (Dordrecht)·Ali Fatehi Hassanabad, Kelsey T MacQueen
Dec 3, 2020·British Journal of Cancer·Suzan BrancherTrond-Eirik Strand
Aug 16, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Li LiYong He
Nov 8, 2019·Seminars in Cancer Biology·Ramanathan KaruppasamyDaisuke Kihara
Nov 2, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Catríona M DowlingKwok-Kin Wong
Aug 11, 2021·Advanced Drug Delivery Reviews·Rajeswari RaguramanRajagopal Ramesh
Aug 26, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Weiling LengQinan Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.